2021

ORPHELIA Pharma raises new money to accelerate its commercial and clinical operations

Newsletter December 2021

This Newsletter is dedicated to the celebration of the 150th project supported by our Corporate Foundation and our Endowment Fund. We hope you enjoy reading it!

ORPHELIA Pharma and K.S. KIM sign a license agreement for the distribution of Kigabeq® in the territory of the Russian federation

Two new projects supported by our Endowment Fund

During the Board of Directors in october 2021, our Institut Dominique & Tom Alberici Endowment Fund supported two new projects: the funding to welcome new members for the Clubhouse Lyon, and the construction of a mini football stadium and rabbit breeding for Madatriso, new association of parents located in Antananarivo

Jeremy Bastid and Hugues Bienayme will participate to the SIOPEN annual meeting to be held 6-8 October in Barcelona

ORPHELIA Pharma is launching its new corporate website

ORPHELIA Pharma and Clinigen sign an exclusive agreement to supply Kigabeq® (vigabatrin)

Newsletter July 2021

Over the past six months, the Foundation and Institute have supported 9 projects that we present to you in this 11th newsletter.

One new project supported by our Foundation Dominique & Tom Alberici

During the Board of Directors in June 2021, our Corporate Foundation supported one new project: the financing of a weekend of hiking for the Clubhouse Lyon.

ORPHELIA Pharma and Gustave Roussy announce issuance of European Patent covering Kimozo®, the first oral liquid formulation of temozolomide